On January 17, Bayer announcedIn progressGlobally Promote"Dynamic Shared Ownership" (DSO)New Operation Model. This model will reduce levels, eliminate bureaucracy, streamline organizations, and expedite decision-making processes, aiming to make Bayer more agile and significantly improve operational efficiency.In this announcement, Bayer particularly emphasizedThere will be no mandatory layoffs before the end of 2026. Employees will be provided with severance packages based on age, necessary time, and other guarantees. The job security agreement will be extended until December 30, 2026.
The layoff plan is expected to be implemented rapidly in the coming months and completed by the end of 2025 at the latest.According to the DSO principle, the layoff planTo a large extent, it is decentralized, which also means that its scope cannot be quantified for the time being.
In November 2023, after releasing its Q3 financial report, Bayer indicated that it was considering a spin-off and restructuring, and decided to significantly reduce its workforce.The management team is the first to be affected.。CEO Bill Anderson believes that "there are too many" 12 layers of management between Bayer and its customers.However, foreign media reported on January 16 that，Germany's Mining, Chemical and Energy Industrial Union (IG BCE) opposes Bayer's plan to split its three major business divisions — Pharmaceuticals, Consumer Health, and Crop Science — due to concerns that many Germans could lose their jobs as a result.Moreover, IG BCE also believes that after the split, Bayer will become very vulnerable and might once again become a takeover target for other pharmaceutical companies. There may also be a risk of Bayer's headquarters moving abroad; for instance, its crop science business could potentially relocate to the United States. It is currently unclear whether the pharmaceuticals business will remain in Germany after the spin-off.However, Bayer also addressed this concern in the statement, saying thatThe Management Committee and employee representatives haveFor future developmentReach an agreement on the direction,Includes several important commitments regarding the German headquarters and its employees. For example, the reaffirmation by both parties ofThe future concept of Germany passed in March 2022; Bayer also plans to further develop its headquarters located in Germany according to the DSO. Both parties have also agreed to improve Bayer's pension plan, etc.。Copyright © 2024 PHARMCUBE. All Rights Reserved.
Welcome to forward, share, and reasonably cite. When citing, please clearly indicate the source of the article in a prominent position;For reprint, please leave a message or send a message to the WeChat Official Account backend, and indicate the name and ID of the official account.
Disclaimer: The information in this WeChat article is for general reference only and should not be used directly as decision-making content. PharmaCube assumes no responsibility for any loss incurred by any party due to the use of the content herein.
